SANTOS DAVID A (EVP, Chief Commercial Officer) reported 1 transaction at RIGEL PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 6/3/2026ACC: 0000905148-26-002810
Officer· EVP, Chief Commercial Officer
Since Aug 2020
-874.00
Net shares
Net seller
$26.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
874.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−874.00
Price / share
$29.86
Trade value
$26.10K
% of position
1.4%
6/1/2026
62.87K→62K
Total
Net shares
−874.00
Net value
-$26.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | F · Tax Withholding | −874.00 | $29.86 | $26.10K | 1.4% | 62.87K | 62K |
| Total | −874.00 | -$26.10K | ||||||
Derivative Transactions0
No derivative transactions reported